-unusually high volume of trading on the TSX today-
BELLEVILLE, ON, April 19, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX:
BNC) (ASX: BNC), a research-based, technology-driven Canadian
biopharmaceutical company, today noted substantial trading volume of
its shares on the Toronto Stock Exchange.
It has come to the Company's attention that one of its institutional
shareholders - the Fonds de solidarité FTQ - has sold their entire
"This has come as a surprise to us as there has been no material change
in our business," stated Mr. Graeme McRae, President & CEO of Bioniche
Life Sciences Inc. "However, we appreciate the number of investors who
have purchased shares today, and we look forward to working with all
shareholders to demonstrate the Company's potential."
About Bioniche Life Sciences Inc.
Bioniche Life Sciences Inc. is a research-based, technology-driven
Canadian biopharmaceutical company focused on the discovery,
development, manufacturing, and marketing of proprietary and innovative
products for human and animal health markets worldwide. The
fully-integrated company employs more than 200 skilled personnel and
has three operating divisions: Human Health, Animal Health, and One
Health. The Company's primary goal is to develop and commercialize
products that advance human or animal health and increase shareholder
value. For more information, please visit www.Bioniche.com.
Except for historical information, this news release may contain
forward-looking statements that reflect the Company's current
expectation regarding future events. These forward-looking statements
involve risk and uncertainties, which may cause, but are not limited
to, changing market conditions, the successful and timely completion of
clinical studies, the establishment of corporate alliances, the impact
of competitive products and pricing, new product development,
uncertainties related to the regulatory approval process, and other
risks detailed from time to time in the Company's ongoing quarterly and
SOURCE Bioniche Life Sciences Inc.